Ioanna Tsea

Artiklar

Article: CANCER LETTERS. 2024;605:217261
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma
Pepich A; Tummler C; Abu Ajamieh S; Treis D; Boje AS; Vellema Q; Tsea I; Akerlund E; Seashore-Ludlow B; Fard SS; Kogner P; Johnsen JI; Wickstrom M
Article: MOLECULAR CANCER. 2024;23(1):180
Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma
Olsen TK; Otte J; Mei S; Embaie BT; Kameneva P; Cheng H; Gao T; Zachariadis V; Tsea I; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Fard SS; Johnsen JI; Kogner P; Adameyko I; Enge M; Kharchenko PV; Baryawno N
Article: GENOME MEDICINE. 2024;16(1):1
Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions
Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu C-L; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
Article: NATURE COMMUNICATIONS. 2022;13(1):5747
A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu C-L; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N

Review: CANCERS. 2023;15(19):4734
Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma
Alchahin AM; Tsea I; Baryawno N
Preprint: BIORXIV. 2022
A new transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma
Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu C-L; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N